Day: April 29, 2021

GUANGZHOU, China, April 28, 2021 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced that it plans to release its unaudited financial results for the first quarter of 2021 before the U.S. market opens on May 25, 2021. Following the release, company management will host a conference call at 8:00 a.m. ET (8:00 p.m. Hong Kong time) on the same day to discuss its financial results for the first quarter of 2021. Details of the conference call are as follows:International: +65 67135090U.S.: +1 8456750437U.K.: +44 2036214779Hong Kong: +852 30186771China Mobile: 4006208038China Landline: 8008190121Conference ID: 6193891A replay of...

GUANGZHOU, China, April 28, 2021 (GLOBE NEWSWIRE) — Fanhua Inc. (“Fanhua” or “the Company”) (Nasdaq: FANH), a leading independent financial services provider in China, today announced that it has filed its 2020 annual report on Form 20-F, which contains its audited financial statements for the fiscal year ended December 31, 2020, with the U.S. Securities and Exchange Commission (the “SEC”) on April 28, 2021. The 2020 20-F can be accessed on the SEC’s website at http://www.sec.gov as well as on the Investor Relations page of the Company’s website at http://ir.fanhuaholdings.com/financial-information/sec-filings. Hard copies of the annual report are available, free of charge, to its shareholders upon request. About Fanhua Inc. Fanhua Inc. is a leading independent financial services provider. Through our online platforms and...

FAIRLESS HILLS, Pa., April 28, 2021 (GLOBE NEWSWIRE) — Hydrofarm Holdings Group, Inc. (“Hydrofarm” or the “Company”) (Nasdaq: HYFM), a leading independent distributor and manufacturer of hydroponics equipment and supplies for controlled environment agriculture, today announced the pricing of an underwritten upsized public offering of 4,805,967 shares of its common stock at a public offering price of $59.00 per share. The net proceeds to the Company from this offering, after deducting the underwriting discounts and commissions and estimated offering expenses payable by the Company, are expected to be approximately $269.3 million. All shares of common stock are being offered by Hydrofarm. In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 720,894 of its common stock at the public...

VANCOUVER, British Columbia, April 28, 2021 (GLOBE NEWSWIRE) — Major Precious Metals Corp. (“Major Precious Metals” or the “Company”) (CSE:SIZE | OTC:SIZYF | FRANKFURT:3EZ) wishes to confirm that management is unaware of any material change in the Company’s operations that would account for the recent significant share price depreciation, following the successful report of its 5.5 million palladium equivalent indicated resource and 14.4 million palladium equivalent ounce inferred resource at Skaergaard. The Company has been informed by its advisors that sophisticated techniques including spoofing, layering, wash trading, manipulation through multiple brokerage houses and the use of aggressive algorithms targeting the bid/offer designed to give the appearance of weakness in the Company’s shares have been utilized in...

CALGARY, Alberta and TORONTO, April 28, 2021 (GLOBE NEWSWIRE) — Magnetic North Acquisition Corp. (TSXV: MNC; MNC.PR.A) (“Magnetic North” or the “Company”) announces that it will not meet the filing date for filing of the following continuous disclosure documents (collectively, the “Documents”):the Company’s Annual Audited Financial Statements for the 15 months ended December 31, 2020, as required by section 4.2 of National Instrument 51-102 – Continuous Disclosure Obligations (“NI 51-102”); and the Company’s Management Discussion & Analysis for the 15 months ended December 31, 2020, as required by section 5.1(2) of NI 51-102.The default is due, in part, to business and administrative disruption experienced by the Company in respect of both its own personnel and the Company’s auditors inability to complete the work...

GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British business LONDON, April 29, 2021 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and commercialising regulatory approved cannabis-based medicines, announces that it has received the Queen’s Award for Enterprise 2021 in the Innovation category, recognising GW’s innovative and ground-breaking work to harness cannabinoid science to create the world’s first regulatory approved, prescription cannabis-based medicines. Since its inception in 1998, GW has successfully navigated significant barriers to enable the development, manufacture and commercialisation of regulatory approved cannabis-based medicines,...

GW’s ground-breaking medicines development programme recognised for outstanding achievement in innovation with UK’s highest official award for British business LONDON, April 29, 2021 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), a world leader in discovering, developing and commercialising regulatory approved cannabis-based medicines, announces that it has received the Queen’s Award for Enterprise 2021 in the Innovation category, recognising GW’s innovative and ground-breaking work to harness cannabinoid science to create the world’s first regulatory approved, prescription cannabis-based medicines. Since its inception in 1998, GW has successfully navigated significant barriers to enable the development, manufacture and commercialisation of regulatory approved cannabis-based medicines,...

BOSTON, April 28, 2021 (GLOBE NEWSWIRE) — Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases, today announced that Richard Peters, M.D., Ph.D., President and Chief Executive Officer, will present at the 2021 B. Riley Securities’ Neuroscience Conference. The presentation will be available on-demand via the conference portal and through the Company’s website at www.yumanity.com/events beginning at 2:30 p.m. EDT, April 29. About Yumanity TherapeuticsYumanity Therapeutics is a clinical-stage biopharmaceutical company dedicated to accelerating the revolution in the treatment of neurodegenerative diseases through its scientific foundation and drug discovery platform. The Company’s most...

FRISCO, TEXAS, April 28, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Verde Bio Holdings, Inc. (OTC: VBHI), filed a 253(g) Supplement with the U.S. Securities & Exchange Commission on Wednesday April 28, 2021 which erroneously stated that the number of shares being offered under the Regulation A offering was being increased to 10,000,000,000 shares. A subsequent 253(g) Supplement was filed correcting this error.  The correct number of shares being offered is one billion (1,000,000,000) at the price of $0.01 per share pursuant the Regulation A offering.  Once all of the one billion shares are sold, the offering will close.  Verde Bio Holdings, Inc. regrets any confusion which this erroneous filing may have caused.  “With the recent announcement of settlement of all debt, the Company is moving forward with a strong balance...